Moxifloxacin versus ethambutol in the first 2 months of treatment for pulmonary tuberculosis. [electronic resource]
Producer: 20060831Description: 331-8 p. digitalISSN:- 1073-449X
- Adult
- Africa
- Antitubercular Agents -- administration & dosage
- Aza Compounds -- adverse effects
- Drug Administration Schedule
- Drug Therapy, Combination
- Ethambutol -- adverse effects
- Female
- Fluoroquinolones
- Humans
- Male
- Moxifloxacin
- Mycobacterium tuberculosis -- isolation & purification
- Quinolines -- adverse effects
- Sputum -- microbiology
- Tuberculosis, Pulmonary -- drug therapy
- United States
No physical items for this record
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.